Columbia University College of Physicians & Surgeons/New York-Presbyterian Hospital, New York, NY.
Center for Acute Respiratory Failure, Columbia University Medical Center, New York, NY.
Crit Care Med. 2019 Oct;47(10):1346-1355. doi: 10.1097/CCM.0000000000003910.
To characterize physicians' practices and attitudes toward the initiation, limitation, and withdrawal of venovenous extracorporeal membrane oxygenation for severe respiratory failure and evaluate factors associated with these attitudes.
Electronic, cross-sectional, scenario-based survey.
Extracorporeal membrane oxygenation centers affiliated with the Extracorporeal Life Support Organization and the International Extracorporeal Membrane Oxygenation Network.
Attending-level physicians with experience managing adult patients receiving venovenous extracorporeal membrane oxygenation.
None.
Five-hundred thirty-nine physicians in 39 countries across six continents completed the survey. Factors that influenced the decision to limit extracorporeal membrane oxygenation initiation included older patient age (46.9%), additional organ failures (37.7%), and prolonged mechanical ventilation (35.1%). Patient comorbidities (70.5%), patient's wishes (56.0%), and etiology of respiratory failure (37.7%) were factors that influenced the decision to withdraw extracorporeal membrane oxygenation. In multivariable analysis, factors associated with increased odds of withdrawing life-sustaining therapies included pulmonary fibrosis, stroke, surrogate's desire to withdraw, lack of knowledge regarding patient's or surrogate's wishes in the setting of fibrosis, not initiating extracorporeal membrane oxygenation in the baseline scenario, and respondent religiosity. Factors associated with decreased odds of withdrawal included practicing in an environment where it is not legally possible to make decisions against patient or surrogate wishes. Most respondents (90.5%) involved other physicians in treatment decisions for extracorporeal membrane oxygenation patients, whereas only 53.2%, 45.3%, and 29.5% of respondents involved surrogates, awake patients, or bedside nurses, respectively.
Patient and physician-level factors were associated with decision-making regarding extracorporeal membrane oxygenation initiation and withdrawal, including patient prognosis and knowledge of patient or surrogate wishes. Respondents reported low rates of engaging in shared decision-making when managing patients receiving extracorporeal membrane oxygenation.
描述医生在启动、限制和停止体外膜肺氧合治疗严重呼吸衰竭方面的实践和态度,并评估与这些态度相关的因素。
电子、横断面、基于情景的调查。
与体外生命支持组织和国际体外膜氧合网络有关的体外膜肺氧合中心。
有管理接受静脉-静脉体外膜肺氧合治疗的成年患者经验的主治医生。
无。
来自六大洲 39 个国家的 539 名医生完成了这项调查。影响限制体外膜肺氧合启动的决定的因素包括患者年龄较大(46.9%)、合并其他器官衰竭(37.7%)和机械通气时间延长(35.1%)。患者合并症(70.5%)、患者的意愿(56.0%)和呼吸衰竭的病因(37.7%)是影响停止体外膜肺氧合的决定因素。在多变量分析中,与增加停止生命支持治疗的可能性相关的因素包括肺纤维化、中风、代理人希望撤回、在纤维化背景下缺乏对患者或代理人意愿的了解、在基线情况下未启动体外膜肺氧合,以及受访者的宗教信仰。与降低撤回可能性相关的因素包括在无法合法做出违背患者或代理人意愿的决定的环境中执业。大多数受访者(90.5%)在体外膜肺氧合患者的治疗决策中涉及其他医生,而只有 53.2%、45.3%和 29.5%的受访者分别涉及代理人、清醒患者或床边护士。
患者和医生层面的因素与体外膜肺氧合的启动和停止决策相关,包括患者的预后和对患者或代理人意愿的了解。受访者在管理接受体外膜肺氧合治疗的患者时报告了低比例的共同决策。